United States · Series D startup
5 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$162Mraised across 5 rounds since 2011, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $80M sold, first sale Nov 2014
No investor was named in the report.
From a historical funding recordSEC filing: $25M sold, first sale May 2014
Adams Street Partners
Genesys Capital
Savitr CapitalReported by fiercebiotech.comSEC filing: $38M sold, first sale Dec 2012
Adams Street PartnersGenesys CapitalReported by fiercebiotech.comSEC filing: $11M sold, first sale May 2011
No investor was named in the report.
Reported by sec.govSEC filing: $1.1M sold, first sale Jun 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Adams Street PartnersGenesys CapitalPathoCapitalDruid BioVenturesBaxter VenturesTakeda VenturesSavitr CapitalFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Naurex's investors include Adams Street Partners, Latterell Venture Partners, Genesys Capital, PathoCapital and Druid BioVentures, and 3 more on record.
Naurex has raised $162M across 5 rounds since 2011.
Naurex's most recent round was a Series D of $80M in Dec 2014.
Its most recent round, $80M in Dec 2014, is also its largest on record.
Naurex's first round on record, in May 2011, was backed by Adams Street Partners, Latterell Venture Partners and Genesys Capital and 3 others.
Naurex's latest named round is a Series D, in Dec 2014.
Naurex is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·